Outcomes of using Firebird rapamycin eluting stents in routine coronary intervention practice: one-year results from the pilot study of Firebird in China registry
摘要篇首: Recent clinical trials with rapamycin-eluting stents have shown very low restenosis rates.1-4 However, the higher penetration of drug eluting stent (DES) in China is being limited by the high costs of these imported devices, especially when considering multiple stenting.
更多相关知识
- 浏览85
- 被引29
- 下载8

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文